Cognitive Decline, Focus Deficit
Conditions
Keywords
Cognitive Health, Functional Mushrooms
Brief summary
This is a single-arm, open-label, virtual clinical trial evaluating the cognitive health effects of Auri Super Mushroom Daily Gummies in a population of 35 adult participants over 8 weeks. Participants will consume two gummies daily and complete validated cognitive testing and self-assessment questionnaires to assess changes in cognitive performance, energy, mood, memory, and overall well-being.
Interventions
DIETARY_SUPPLEMENTAuri Super Mushroom Daily Gummies
Each gummy contains a blend of 12 functional mushroom extracts (300 mg equivalent each).
Sponsors
Citruslabs
Auri Nutrition
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Be male or female * Be aged 30+ * Anyone who has been experiencing issues consistently for the last four weeks regarding all of the following: Forgetfulness Inability to focus Low energy levels Low mood * Anyone who is generally healthy - does not live with any uncontrolled chronic disease * Willing to stop any other products or any medication or supplements that target cognition or cognitive health for the study duration * Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study * Not undergone any surgeries or invasive treatments in the last six months * Not had any major illness in the last three months * Resides in the United States * Not currently partaking in another research study and will not be partaking in any other research study for the next 8 weeks and at any point during this study's duration * Willing to consult with their healthcare provider before enrolling in the study if taking any prescription medication
Exclusion criteria
* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with any allergies or sensitivities to any of the study product ingredients * Anyone taking immunosuppressants * Anyone taking blood thinners (anticoagulants) * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period) * Anyone unwilling to follow the study protocol * Anyone with a history of substance abuse * Anyone with intolerance or sensitivity to mushrooms
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Cognitive Performance - Digit Span Test | Baseline, Week 2, Week 4, Week 6, and Week 8 | The Digit Span test measures working memory capacity. Participants are presented with a series of numbers and asked to recall them in order. Performance is scored based on the total number of correctly recalled sequences. Scale Name: Digit Span Score Range: 0 to 14 Direction: Higher scores indicate better cognitive performance. |
| Change in Cognitive Performance - Paired Associates Test | Baseline, Week 2, Week 4, Week 6, Week 8 | The Paired Associates task assesses memory by asking participants to recall which items were previously paired together. Score is based on the number of correct associations recalled. Scale Name: Paired Associates Score Range: 0 to 12 Direction: Higher scores indicate better cognitive performance. |
| Change in Attention and Processing Speed - Double Trouble Task | Baseline, Week 2, Week 4, Week 6, Week 8 | Double Trouble is a Stroop-like task that measures attention control and response inhibition. Performance is measured by accuracy (%) and completion time (seconds). Scale Name: Double Trouble Accuracy (%) Range: 0 to 100 Direction: Higher percentage indicates better attention and cognitive control. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self-Reported Focus - Questionnaire Score | Baseline, Week 2, Week 4, Week 6, and Week 8 | Participants rate their ability to focus using a Likert-style scale. Scale Name: Focus Rating Scale (1-10) Range: 1 (poor focus) to 10 (excellent focus) Direction: Higher scores indicate better focus |
| Self-Reported Memory - Questionnaire Score | Baseline, Week 2, Week 4, Week 6, and Week 8 | Participants self-assess memory retention using a 10-point Likert scale. Scale Name: Memory Rating Scale (1-10) Range: 1 (poor memory) to 10 (excellent memory) Direction: Higher scores indicate better memory |
Countries
United States
Outcome results
None listed